155 related articles for article (PubMed ID: 35986249)
61. Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients.
Gresham G; Renouf DJ; Chan M; Kennecke HF; Lim HJ; Brown C; Cheung WY
Ann Surg Oncol; 2014 Nov; 21(12):3917-23. PubMed ID: 24859937
[TBL] [Abstract][Full Text] [Related]
62. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
Grothey A; Flick ED; Cohn AL; Bekaii-Saab TS; Bendell JC; Kozloff M; Roach N; Mun Y; Fish S; Hurwitz HI
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):726-34. PubMed ID: 24830357
[TBL] [Abstract][Full Text] [Related]
63. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
64. A Comparison of Survival by Site of Metastatic Resection in Metastatic Colorectal Cancer.
Lee-Ying R; Bernard B; Gresham G; Chen L; Speers C; Kennecke HF; Lim HJ; Cheung WY; Renouf DJ
Clin Colorectal Cancer; 2017 Jun; 16(2):e23-e28. PubMed ID: 27637559
[TBL] [Abstract][Full Text] [Related]
65. Metastatic colo-rectal cancer: real life experience from an Indian tertiary care center.
Sharma V; Sharma A; Raina V; Dabkara D; Mohanti BK; Shukla NK; Pathy S; Thulkar S; Deo SVS; Kumar S; Sahoo RK
BMC Cancer; 2021 May; 21(1):630. PubMed ID: 34049505
[TBL] [Abstract][Full Text] [Related]
66. Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort.
Rouyer M; François E; Cunha AS; Monnereau A; Noize P; Robinson P; Droz-Perroteau C; Le Monies de Sagazan A; Jové J; Lassalle R; Moore N; Fourrier-Réglat A; Smith D;
Clin Colorectal Cancer; 2018 Jun; 17(2):129-139. PubMed ID: 29523416
[TBL] [Abstract][Full Text] [Related]
67. Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.
Tuncel T; Ozgun A; Emirzeoglu L; Celik S; Bilgi O; Karagoz B
Asian Pac J Cancer Prev; 2014; 15(15):6421-3. PubMed ID: 25124636
[TBL] [Abstract][Full Text] [Related]
68. Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
Alese OB; Zakka K; Huo X; Jiang R; Shaib WL; Akce M; Behera M; Sullivan P; Wu C; El-Rayes BF
J Surg Oncol; 2021 Feb; 123(2):596-605. PubMed ID: 33125756
[TBL] [Abstract][Full Text] [Related]
69. Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.
Modest DP; Denecke T; Pratschke J; Ricard I; Lang H; Bemelmans M; Becker T; Rentsch M; Seehofer D; Bruns CJ; Gebauer B; Modest HI; Held S; Folprecht G; Heinemann V; Neumann UP
Eur J Cancer; 2018 Jan; 88():77-86. PubMed ID: 29195117
[TBL] [Abstract][Full Text] [Related]
70. Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer.
Aljehani MA; Morgan JW; Guthrie LA; Jabo B; Ramadan M; Bahjri K; Lum SS; Selleck M; Reeves ME; Garberoglio C; Senthil M
JAMA Surg; 2018 Jan; 153(1):60-67. PubMed ID: 28975237
[TBL] [Abstract][Full Text] [Related]
71. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
72. Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI ± Bevacizumab: A Western Canadian Province Experience.
Bhatti T; Moser M; Tan KT; Chalchal H; Souied O; Le D; Shaw J; Zaidi A; Gill D; Ahmed S
J Gastrointest Cancer; 2022 Jun; 53(2):427-433. PubMed ID: 33779898
[TBL] [Abstract][Full Text] [Related]
73. Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer.
Blauwhoff-Buskermolen S; Versteeg KS; de van der Schueren MA; den Braver NR; Berkhof J; Langius JA; Verheul HM
J Clin Oncol; 2016 Apr; 34(12):1339-44. PubMed ID: 26903572
[TBL] [Abstract][Full Text] [Related]
74. SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer.
Huang L; Zhang T; Xie C; Liao X; Yu Q; Feng J; Ma H; Dai J; Li M; Chen J; Zang A; Wang Q; Ge S; Qin K; Cai J; Yuan X
PLoS One; 2013; 8(10):e77223. PubMed ID: 24143213
[TBL] [Abstract][Full Text] [Related]
75. Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study.
Lu L; Zhuang T; Shao E; Liu Y; He H; Shu Z; Huang Y; Yao Y; Lin S; Lin S; Chen X; Chen X
PLoS One; 2019; 14(9):e0221964. PubMed ID: 31504043
[TBL] [Abstract][Full Text] [Related]
76. Using a Lymph Node Count Metric to Identify Underperforming Hospitals After Rectal Cancer Surgery.
Raoof M; Zafar SN; Ituarte PHG; Krouse RS; Melstrom K
J Surg Res; 2019 Apr; 236():216-223. PubMed ID: 30694758
[TBL] [Abstract][Full Text] [Related]
77. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; O'Neil BH; Shaw JE; Polite BN; Hochster HS; Atkins JN; Goldberg RM; Sato K; Ng K; Van Blarigan E; Mayer RJ; Blanke CD; O'Reilly EM; Fuchs CS; Meyerhardt JA
J Clin Oncol; 2019 Oct; 37(29):2620-2631. PubMed ID: 31408415
[TBL] [Abstract][Full Text] [Related]
78. Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: results from the South Australian Metastatic Colorectal Cancer Registry.
McNeill D; Karapetis CS; Price TJ; Meagher P; Piantadosi C; Quinn S; Roder D; Padbury R; Maddern G; Townsend A; Jayawardana MW; Roy AC
Intern Med J; 2021 Jan; 51(1):69-77. PubMed ID: 31985128
[TBL] [Abstract][Full Text] [Related]
79. Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
Vallance AE; van der Meulen J; Kuryba A; Braun M; Jayne DG; Hill J; Cameron IC; Walker K
Eur J Surg Oncol; 2018 Oct; 44(10):1588-1594. PubMed ID: 29895508
[TBL] [Abstract][Full Text] [Related]
80. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
Magaji BA; Moy FM; Roslani AC; Law CW
BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
